116 related articles for article (PubMed ID: 21275327)
1. Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer.
Wilkes GM
Oncology (Williston Park); 2010 Oct; 24(10 Suppl):46-8. PubMed ID: 21275327
[No Abstract] [Full Text] [Related]
2. Doxetaxel: new indication. Prostate cancer: a few more weeks.
Prescrire Int; 2006 Feb; 15(81):6-7. PubMed ID: 16548096
[TBL] [Abstract][Full Text] [Related]
3. Drug evaluation: tesetaxel--an oral semisynthetic taxane derivative.
Roche M; Kyriakou H; Seiden M
Curr Opin Investig Drugs; 2006 Dec; 7(12):1092-9. PubMed ID: 17209527
[TBL] [Abstract][Full Text] [Related]
4. The continuing challenge of hormone-refractory prostate cancer.
Sartor O
Clin Genitourin Cancer; 2006 Mar; 4(4):238-9. PubMed ID: 16729904
[No Abstract] [Full Text] [Related]
5. [Hormone-refractory metastatic prostate carcinoma -- combination improves survival].
Aktuelle Urol; 2005 Sep; 36(5):385-7. PubMed ID: 16163602
[No Abstract] [Full Text] [Related]
6. New progress in treatment of hormone-refractory prostate cancer.
Ahmad K
Lancet Oncol; 2004 Dec; 5(12):706. PubMed ID: 15599999
[No Abstract] [Full Text] [Related]
7. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review.
Engels FK; Sparreboom A; Mathot RA; Verweij J
Br J Cancer; 2005 Jul; 93(2):173-7. PubMed ID: 16012521
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel: a tubulin-stabilizing agent approved for the management of several solid tumors.
Ramaswamy B; Puhalla S
Drugs Today (Barc); 2006 Apr; 42(4):265-79. PubMed ID: 16703123
[TBL] [Abstract][Full Text] [Related]
9. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer.
Sorscher SM
Cancer Chemother Pharmacol; 2004 Aug; 54(2):191-2. PubMed ID: 15148627
[TBL] [Abstract][Full Text] [Related]
10. Loss of SLCO1B3 drives taxane resistance in prostate cancer.
de Morrée ES; Böttcher R; van Soest RJ; Aghai A; de Ridder CM; Gibson AA; Mathijssen RH; Burger H; Wiemer EA; Sparreboom A; de Wit R; van Weerden WM
Br J Cancer; 2016 Sep; 115(6):674-81. PubMed ID: 27537383
[TBL] [Abstract][Full Text] [Related]
11. [The action and toxicity of taxanes].
Lipp HP; Bokemeyer C
Pharm Unserer Zeit; 2005; 34(2):128-37. PubMed ID: 15803797
[No Abstract] [Full Text] [Related]
12. Taxanes.
Nurs Times; 2006 Jul 25-31; 102(30):37. PubMed ID: 16903306
[No Abstract] [Full Text] [Related]
13. Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care.
Heidenreich A; Pfister D
Eur Urol; 2012 Dec; 62(6):1201-4. PubMed ID: 22964168
[No Abstract] [Full Text] [Related]
14. [Longer life in hormone refractory prostatic carcinoma].
Krankenpfl J; 2005; 43(4-6):140-1. PubMed ID: 16173125
[No Abstract] [Full Text] [Related]
15. Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation.
Gupta S; Silliman CG; Trump DL
Prostate Cancer Prostatic Dis; 2007; 10(4):396-7. PubMed ID: 17404582
[TBL] [Abstract][Full Text] [Related]
16. New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.
Sava T; Basso U; Porcaro A; Cetto GL
Expert Rev Anticancer Ther; 2005 Feb; 5(1):53-62. PubMed ID: 15757438
[TBL] [Abstract][Full Text] [Related]
17. [Paclitaxel and docetaxel safe use: pharmacokinetics and potential interactions of taxanes].
Simons S; Jaehde U
Pharm Unserer Zeit; 2005; 34(2):122-7. PubMed ID: 15803796
[No Abstract] [Full Text] [Related]
18. The impact of taxanes on the management of genitourinary cancers.
Balar AV
Anticancer Drugs; 2014 May; 25(5):555-60. PubMed ID: 24525590
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel in androgen-independent prostate cancer: an update.
Khan MA; Carducci MA; Partin AW
BJU Int; 2004 Dec; 94(9):1209-10. PubMed ID: 15610087
[No Abstract] [Full Text] [Related]
20. Quality-of-life considerations with taxane-based therapy in metastatic breast cancer.
Maxwell C
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():35-40. PubMed ID: 23360701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
